Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

Clinical trial NCT01724268 · UNKNOWN

Trial details

NCT number: NCT01724268
Sponsor: Hamad Medical Corporation
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

RHEUMATOID ARTHRITIS

Start date: 2012-05-01
Primary completion: 2014-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.